Welcome to European Pharmaceutical Review. This site uses cookies. Read our policy.
2023-06-21T14:00:00
Doug Botkin, PhD, examines the challenges and consequences of inaccurate microbial identification methods using real-world case studies and discusses how these challenges can be addressed.